A 21st-century approach to age-old problems: The ascension of biologics in clinical therapeutics

Drug Discovery Today

Volumn 19, Issue 8, 2014, Pages 1109-1113

  Espiritu, Michael J ^a   Collier, Abby C ^b   Bingham, Jon Paul ^a  

^a UNIVERSITY OF HAWAII AT MANOA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CANCER VACCINE; COLISTIN; ENFUVIRTIDE; GLYX 13; HIRUDIN; INSULIN; MONOCLONAL ANTIBODY; OMEGA CONOTOXIN MVIIA; PEPTIDE DERIVATIVE; RAPASTINEL; RESTRICTION ENDONUCLEASE; RNA INDUCED SILENCING COMPLEX; SILDENAFIL; SMALL MOLECULE TRANSPORT AGENT; TADALAFIL; UNCLASSIFIED DRUG; VARDENAFIL; BIOLOGICAL PRODUCT; PROTEIN;

BIOLOGICAL THERAPY; BIOTECHNOLOGY; CLINICAL EFFECTIVENESS; CYCLIZATION; DRUG BIOAVAILABILITY; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; GENE SILENCING; GENE THERAPY; GENETIC ENGINEERING; GENOMICS; HUMAN; PERSONALIZED MEDICINE; PROTEOMICS; REVIEW; RNA INTERFERENCE; ANIMAL; GENETICS; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOLOGICAL PRODUCTS; BIOTECHNOLOGY; GENETIC THERAPY; GENOMICS; HUMANS; PROTEINS; PROTEOMICS; RNA INTERFERENCE;

EID: 84906305745     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.01.008     Document Type: Review

References (45)

1. Celera Science genome map Science 291 2001 1218
2. D.L. Pavia et al. Aspirin D. Harris, Introduction to Organic Laboratory Techniques: A Microscale Approach 2007 Thomson Brooks/Cole 61 63
3. Bayer Management Report Vol. 2013 2012 Bayer
4. M. Angell Excess in the pharmaceutical industry Can. Med. Assoc. J. 171 2004 1451 1453
5. T.F. Gajewski Cancer immunotherapy Mol. Oncol. 6 2012 242 250
6. M. Adamczyk et al. The use of electrospray ionization mass spectrometry to distinguish the lot-to-lot heterogeneity of an antigen specific monoclonal antibody from a specific cellular clone J. Eur. Mass Spectrom. 5 1999 165 168
7. FDA Drugs@FDA Vol. 2013 2013 FDA
8. F. Sanger Determination of nucleotide sequences in DNA Biosci. Rep. 24 2004 237 253
9. P. Edman Method for determination of the amino acid sequence in peptides Acta Chem. Scand. 4 1950 34
10. B. Merrifield Solid phase synthesis Science 232 1986 341 347
11. J.B. Fenn et al. Electrospray ionization for mass spectrometry of large biomolecules Science 246 1989 64 71
12. K. Tanaka et al. Protein and polymer analyses up to m/z 100 000 by laser ionization time of flight mass spectrometry Rapid Commun. Mass Spectrom. 2 1988 151 153
13. F. Hillenkamp, and M. Karas [12] Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization Methods Enzymol. 193 1990 280 295
14. D.A. Jackson et al. Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 69 1972 2904 2909
15. G. Winter Greg Winter Nat. Biotechnol. 29 2011 190
16. B.R. Glick, and J.J. Pasternak Therapeutic Agents: Preventing rejection of transplanted organs Molecular Biotechnology 2003 ASM Press American Society for Microbiology Washington, DC 256 308
17. R.K. Oldham, and R.O. Dillman Monoclonal antibodies in cancer therapy: 25 years of progress J. Clin. Oncol. 26 2008 1774 1777
18. S. Yoshioka, and V.J. Stella Stability of peptide and protein pharmaceuticals In Stability of Drugs and Dosage Forms 2000 Kluwer Academic/Plenum Publishers New York, New York 193 194
19. R. Lax The future of peptide development in the pharmaceutical industry Phar. Manufacturing Int. Peptide Rev. 2010 Sept. 10-15
20. J.-P. Bingham et al. Drugs from slugs. Part II: conopeptide bioengineering ChemBiol. Interact. 200 2012 92 113
21. J. Burgdorf et al. The N-methyl-d-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats Neurobiol. Aging 32 2011 698 706
22. J.P. Lalezari et al. A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy AIDS 17 2003 691 698
23. C.M.B. Edwards et al. Peptides as drugs QJM 92 1999 1 4
24. J.P. Tam, and C.T.T. Wong Chemical synthesis of circular proteins J. Biol. Chem. 287 2012 27020 27025
25. C.L. Slingluff Jr. The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination? Cancer J. 17 2011 343 350
26. M. Cemazar et al. Discovery and applications of disulfide-rich cyclic peptides Curr. Top. Med. Chem. 12 2012 1534 1545
27. M.J. Espiritu et al. Incorporation of post-translational modified amino acids as an approach to increase both chemical and biological diversity of conotoxins and conopeptides Amino Acids 46 2013 125 151
28. A.F. Altelaar et al. Next-generation proteomics: towards an integrative view of proteome dynamics Nat. Rev. Genet. 14 2013 35 48
29. S.D. Cederbaum et al. Recombinant DNA in Medicine West. J. Med. 141 1984 210 222
30. J.E. Mertz, and R.W. Davis Cleavage of DNA by R 1 restriction endonuclease generates cohesive ends Proc. Natl. Acad. Sci. U. S. A. 69 1972 3370 3374
31. Z. Vajo et al. Recombinant DNA technology in the treatment of diabetes: insulin analogs Endocr. Rev. 22 2001 706 717
32. Altman, L. (1982) A new insulin given approval for use in US. New York Times, 30 September
33. L.A. Palomares et al. Production of recombinant proteins challenges and solutions P.B.A. Lawrence, Recombinant Gene Expression Review and Protocols Vol. XVI 2004 Humana Press 15 51
34. K.A. Ahmed et al. Progress in gene therapy for prostate cancer Front. Oncol. 2 2012 Article number: 00172
35. C. Sheridan Gene therapy finds its niche Nat. Biotechnol. 29 2011 121 128
36. S. Hacein-Bey-Abina et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419
37. C.J.D. Ross et al. Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation Arterioscl. Thromb. Vasc. Biol. 25 2005 2143 2150
38. D. Bumcrot et al. RNAi therapeutics: a potential new class of pharmaceutical drugs Nat. Chem. Biol. 2 2006 711 719
39. A. Reynolds et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent RNA 12 2006 988 993
40. D. Grimm et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways Nature 441 2006 537 541
41. E.J. Sontheimer Assembly and function of RNA silencing complexes Nat. Rev. Mol. Cell. Biol. 6 2005 127 138
42. M.S. Shim, and Y.J. Kwon Efficient and targeted delivery of siRNA in vivo FEBS J. 277 2010 4814 4827
43. H. Büning Gene therapy enters the pharma market: the short story of a long journey EMBO Mol. Med. 5 2013 1 3
44. Amato, S. (2013) Biosimilars: not so similar to FDA generic drug approvals. BioIT World, 3 January
45. M. Nap et al. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen Cancer Res. 52 1992 2329 2339